Cardiovascular Disease

Global CVD Almanac

JACC released a special “almanac-style” issue highlighting the growing burden of cardiovascular disease worldwide. 

The Global Burden of Disease, Injuries, and Risk Factors study (GBD) is the world’s largest effort to track population cardiovascular health, recording global, regional, and national trends in mortality and disability since 1990. 

The analysis found that CVD remains the leading cause of death worldwide, responsible for 20M deaths and 400M disability-adjusted life-years lost in 2021. Here are the ACC’s main 2021 takeaways:

  • Ischemic heart disease was the leading cause of CV death, accounting for 9.4M deaths.
  • High systolic BP remained the leading modifiable risk factor for CV deaths, accounting for 10.8M. 
  • Dietary risks (like too few healthy and too many unhealthy foods) accounted for 6.6M CV deaths. 
  • CVD risk attributable to elevated systolic blood pressure was highest in Central Asia, Central Sub-Saharan Africa, and Eastern Europe.
  • CVD burden attributable to dietary risks was highest in Central Asia, Oceania, and Eastern Europe.
  • Central Asia had the highest age-standardized total CVD mortality at 517 deaths per 100k people, nearly 7 times higher than in Asia Pacific. 

On a brighter note, Australasia had the largest reduction (64.2%) in age-standardized CVD per 100k out of all other regions since 1990, driven by decreases in ischemic heart disease. 

The Takeaway

The ACC hopes to bring renewed attention to troubling trends related to the global CVD burden. The multi-year collaboration helps move the field forward by not only tracking CV risk and disease but also gauging whether interventions are actually effective. 

You might also like

Cardiology Practices September 18, 2025

What Cardiologists Say vs. What Patients Hear September 18, 2025

Cardiovascular risk communication might be failing patients when they need it most, after the HARIPA study revealed significant disconnects between patient and physician perceptions of future cardiovascular risk and procedural complications. The HARIPA study surveyed cardiology inpatients and their physicians from October 2022 to March 2023, using structured questionnaires to assess risk perception and communication […]

Digital Health September 15, 2025

TRICORDER Shows Potential of AI Stethoscopes September 15, 2025

Results from the massive TRICORDER study suggest Eko Health’s AI-powered stethoscopes could change the way primary care providers perform cardiac screening, potentially catching thousands more patients for cardiologists to treat. The TRICORDER study results encompassed 205 NHS GP practices over 12 months, with nearly 1,000 providers performing more than 12.8k AI-stethoscope exams in routine care […]

Cardiology September 11, 2025

Cardiac Wire’s ASE 2025 Takeaways September 11, 2025

The American Society of Echocardiography left an echo this year in Music City as it celebrated its 50th year. Among the studies and products unveiled at ASE 2025, here are Cardiac Wire’s top five takeaways from the meeting. Premium Echo Has Found its Stride – Although most typically think of ultrasound as a lower cost […]

You might also like..

Select All

You're signed up!

It's great to have you as a reader. Check your inbox for a welcome email.

-- The Cardiac Wire Team

You're all set!